344 related articles for article (PubMed ID: 15387897)
21. The renin-angiotensin system and the developing retinal vasculature.
Sarlos S; Wilkinson-Berka JL
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1069-77. PubMed ID: 15728567
[TBL] [Abstract][Full Text] [Related]
22. [Lifestyle-related diseases and anti-aging ophthalmology: suppression of retinal and choroidal pathologies by inhibiting renin-angiotensin system and inflammation].
Ishida S
Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):403-22; discussion 423. PubMed ID: 19348185
[TBL] [Abstract][Full Text] [Related]
23. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
Azizi M
Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
[TBL] [Abstract][Full Text] [Related]
24. Hypertension and diabetes: role of the renin-angiotensin system.
Jandeleit-Dahm K; Cooper ME
Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
[TBL] [Abstract][Full Text] [Related]
25. [Aging and retinal vascular diseases].
Takagi H
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
[TBL] [Abstract][Full Text] [Related]
26. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
27. The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes.
Wilkinson-Berka JL; Kelly DJ; Gilbert RE
J Vasc Res; 2001; 38(6):527-35. PubMed ID: 11740151
[TBL] [Abstract][Full Text] [Related]
28. Retinal neovascularization is prevented by blockade of the renin-angiotensin system.
Moravski CJ; Kelly DJ; Cooper ME; Gilbert RE; Bertram JF; Shahinfar S; Skinner SL; Wilkinson-Berka JL
Hypertension; 2000 Dec; 36(6):1099-104. PubMed ID: 11116132
[TBL] [Abstract][Full Text] [Related]
29. Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies.
Stefansson E; Landers MB; Wolbarsht ML
Ophthalmic Surg; 1983 Mar; 14(3):209-26. PubMed ID: 6190118
[TBL] [Abstract][Full Text] [Related]
30. Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.
Goto K; Fujii K; Kansui Y; Iida M
Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):650-5. PubMed ID: 15479174
[TBL] [Abstract][Full Text] [Related]
31. Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes.
Tikellis C; Cooper ME; Thomas MC
Int J Biochem Cell Biol; 2006; 38(5-6):737-51. PubMed ID: 16198140
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
[TBL] [Abstract][Full Text] [Related]
33. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
34. The retinal renin-angiotensin system: roles of angiotensin II and aldosterone.
Wilkinson-Berka JL; Agrotis A; Deliyanti D
Peptides; 2012 Jul; 36(1):142-50. PubMed ID: 22537944
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-converting enzyme activity and angiomodulatory effects of sera in patients with diabetic retinopathy.
Skopiński P; Sommer E; Borowska A; Hevelke A; Rogala E; Skopińska-Rózewska E
Int J Clin Pharmacol Res; 2001; 21(2):73-8. PubMed ID: 11824650
[TBL] [Abstract][Full Text] [Related]
36. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296
[TBL] [Abstract][Full Text] [Related]
37. Renin-angiotensin-system blockade in the prevention of diabetes.
Ostergren J
Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S13-21. PubMed ID: 17320999
[TBL] [Abstract][Full Text] [Related]
38. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
39. Improving microvascular outcomes in patients with diabetes through management of hypertension.
McGill JB
Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
[TBL] [Abstract][Full Text] [Related]
40. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.
Cooper ME
Am J Hypertens; 2004 Nov; 17(11 Pt 2):16S-20S; quiz A2-4. PubMed ID: 15539106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
